Response to Comment on Knowler et al. Preventing Diabetes in American Indian Communities. Diabetes Care 2013;36:1820–1822

Comment on Knowler et al. Preventing Diabetes in American Indian Communities. Diabetes Care 2013;36:1820–1822

Knowler and Ackermann (1) provided a commentary regarding our article reporting the Special Diabetes Program for Indians Diabetes Prevention (SDPI-DP) demonstration project (2). We deeply appreciate the efforts of the editorial staff in recruiting such a knowledgeable group of diabetes prevention experts to comment on this article. We are especially grateful to the authors for underscoring the ...

Response to Comment on: Draznin et al. Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action. Diabetes Care 2013;36:1807–1814

We are pleased to hear from our British colleagues who agreed with our call to action to engage in more clinical research in order to generate data supporting the benefit of glycemic control in hospitalized patients with diabetes (1,2). This paucity of clinical evidence was indeed the impetus for organizing our consortium PRIDE (Planning Research in Inpatient Diabetes). It is gratifying to lear...

Response to comments on Evert et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes care 2013;36:3821-3842.

Comment on: Wolpert et al. Dietary Fat Acutely Increases Glucose Concentrations and Insulin Requirements in Patients With Type 1 Diabetes: Implications for Carbohydrate-Based Bolus Dose Calculation and Intensive Diabetes Management. Diabetes Care 2013;36:810–816

I read with great interest the recent article by Wolpert et al. (1) in which they compared postprandial responses elicited by lowand high-fat dinner test meals and concluded that dietary fat increases glucose levels and insulin requirements in people with type 1 diabetes. This is consistent with recent results of ours showing that adding 20 g of fat as margarine to 110 g of bread (50 g starch) ...

Response to Comment on: Chakkera et al. Can New-Onset Diabetes After Kidney Transplant Be Prevented? Diabetes Care 2013;36:1406–1412

Hecking et al. raise several important questions in their letter (1). First, compared with classic type 2 diabetes, how important is insulin sensitivity in the development of new-onset diabetes after transplantation (NODAT)? Second, compared with type 1 or type 2 diabetes, is NODAT more rapid in onset? Finally, what are the relative contributions of lifestyle intervention and exogenous insulin ...